Hypoxia-activated chemotherapeutic TH-302 enhances the effects of VEGF-A inhibition and radiation on sarcomas

BACKGROUND: Human sarcomas with a poor response to vascular endothelial growth factor-A (VEGF-A) inhibition and radiation therapy (RT) have upregulation of hypoxia-inducible factor 1α (HIF-1α) and HIF-1α target genes. This study examines the addition of the hypoxia-activated chemotherapy TH-302 to V...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, C, Lee, H-J, Park, D J, Lee, Y-J, Tap, W D, Eisinger-Mathason, T S K, Hart, C P, Choy, E, Simon, M C, Yoon, S S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4647529/
https://www.ncbi.nlm.nih.gov/pubmed/26010414
http://dx.doi.org/10.1038/bjc.2015.186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4647529/
https://www.ncbi.nlm.nih.gov/pubmed/26010414
http://dx.doi.org/10.1038/bjc.2015.186

Ejemplares similares